Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

Original Article

M.N. Kosiborod, M.C. Petrie, B.A. Borlaug, J. Butler, M.J. Davies, G.K. Hovingh, D.W. Kitzman, D.V. Møller, M.B. Treppendahl, S. Verma, T.J. Jensen, K. Liisberg, M.L. Lindegaard, W. Abhayaratna, F.Z. Ahmed, T. Ben-Gal, V. Chopra, J.A. Ezekowitz, M. Fu, H. Ito, M. Lelonek, V. Melenovský, B. Merkely, J. Núñez, E. Perna, M. Schou, M. Senni, K. Sharma, P.v.d. Meer, D.V. Lewinski, D. Wolf, and S.J. Shah

N Engl J Med 2024;390:1394-1407

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Course opens: 
04/17/2024
Course expires: 
04/18/2026

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 Participation
Please sign in or create an account to take the course.